ArticleFrontiers in pharmacology2024
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events.
Long He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this paperpooled itcites it